<DOC>
	<DOCNO>NCT00442741</DOCNO>
	<brief_summary>The purpose extension study evaluate potential inhibitory effect patupilone metabolism use midazolam omeprazole respective probe drug .</brief_summary>
	<brief_title>Evaluate Effects Patupilone Pharmacokinetics Midazolam Omeprazole Patients With Advanced Malignancies ( Extension )</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Epothilone B</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Inclusion criterion : Male female patient 18 year old Histologically document advanced solid tumor , fail standard systemic therapy , standard systemic therapy exist Completed Core study Completed sample core dose reduce Patients adequate hematologic parameter Exclusion criterion : Female patient pregnant breastfeeding . Patients severe and/or uncontrolled medical disease Patients know diagnosis human immunodeficiency virus ( HIV ) infection Patients receive investigational agent within 30 day prior study entry Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Cancer</keyword>
	<keyword>EPO906</keyword>
	<keyword>Patupilone</keyword>
</DOC>